Australian registered nurses who have completed extra training are now able to prescribe some medications in partnership with either a doctor or nurse practitioner.
The updated registration standard, announced in December 2024, comes into effect today and will see RNs with at least three years clinical experience become eligible to apply for an endorsement for prescribing scheduled medicines. They will then undergo a six-month clinical mentorship with an independent prescriber, and be assessed under the National Prescribing Services’ (NPS) Prescribing Competencies Framework.
Key to the new Australian Health Practitioner Regulation Agency (AHPRA) model is a system of ‘partnership prescribing’, wherein endorsed RNs must enter into an agreement with an authorised health practitioner.
The Australian College of Nursing (ACN) has praised the scope of practice expansion, whilst also advocating for increased government support to ensure the changes are implemented smoothly and consistently across the country.
“We congratulate Health Ministers on agreeing to this change in December last year, and the Nursing and Midwifery Board of Australia and Chief Nursing and Midwifery Officers for driving it over many, many years,” ACN chief nursing officer Frances Rice said.

“But we now need the systemic support that will enable this change to truly bring about improvements for people needing health care.”
The ACN said this should include:
- A national communications campaign to increase the awareness of this change across both the healthcare sector and the general public
- Education for employers and authorised health practitioners on supervising and being in a partnership arrangement with a registered nurse
- Access to Pharmaceutical Benefits Scheme (PBS) subsidies for prescriptions provided by a registered nurse prescriber.
The Australian Primary Health Care Nurses Association (APNA) echoes the ACN’s calls for extra support, highlighting the need for specialised training to ensure a harmonious rollout.
“This is something the Australian Primary Health Care Nurses and other nursing organisations have advocated for over a long period. It’s a really positive change, that can make a tremendous difference for patients in primary health care,” APNA president Denise Lyons said.
“This is a cost-effective intervention, that allows people to receive required medications more quickly, particularly in rural and remote locations, reducing wait times, and easing access to essential treatments. It will allow designated registered nurse prescribers to deliver more holistic and person-centred care, enabling continuity and smoother patient journeys.”
Under the updated standards endorsed RNs will be able to prescribe scheduled medicines 2. Pharmacy Medicine, 3. Pharmacist Only Medicine, 4. Prescription Only Medicine, and 8. Controlled Drugs, meaning many patients will be able to obtain the prescriptions they need without waiting for an appointment with their GP.
Ms Rice said the changes have the potential to revolutionise the delivery of quality, efficient, and accessible care for many Australians.
“This change means that, for example, a registered nurse prescriber may be able to support a person adjust their diabetes medication, instead of that person having to find a scarce appointment to see a GP to do so,” she said.
“This increases access to care, and boosts healthcare efficiency by allowing a registered nurse to work to the top of their scope. Further, it takes pressure off nurse practitioners and medical practitioners and allows them to focus on more complex cases.”
For more information visit the the Australian Nursing and Midwifery Accreditation Council website.
